RecruitingNCT07254117

The Role of Granulation Tissue in Periodontal Regeneration

The Role of Biochemical and Microbiological Properties of Granulation Tissue in Periodontal Regeneration

Sponsor

Riga Stradins University

Enrollment

46 participants

Start Date

May 29, 2025

Study Type

OBSERVATIONAL

Conditions

Periodontal Diseases Periodontitis Periodontal Disease Periodontal Regeneration Periodontal Bone Loss Periodontal Granulation Tissue Vertical Periodontal Bone Defects Periodontal Healing

Summary

The goal of this observational study is to distinguish the infectious, healing, and regeneration-related characteristics of two types of gingival granulation tissues, namely infra-osseous and supra-osseous granulation tissues, in people with severe periodontitis (gum disease). Researchers aim to denote if these tissues may play role in healing after periodontal treatment. Researchers will also compare smokers and non-smokers to see if smoking disrupts the healing potential or infectious properties of granulation tissue. Participants will provide gingival fluid (before) and granulation tissue samples (at the time of) periodontal surgery. The main questions this study aims to answer are: 1. Do infra- and supra-osseous granulation tissues have different healing potential and infectious properties? 2. How do these tissues differ in people who smoke compared to people who do not smoke?

Eligibility

Inclusion Criteria6

Both genders.
Systemically healthy.
Both smokers (smoking at least 10 cigarettes a day or electronic cigarettes daily or quit less than 5 years ago) and non-smokers (never smoked, smoke no more than once a month or quit at least 5 years ago).
Patients aged 18 years and over.
Patients with a history of severe periodontitis (stage III or IV, grade B-C) and, after completion of the non-surgical stage of periodontal treatment with at least one residual vertical bone defects (with ≥3 mm infrabony component) in premolar-molar region.
Patients with a plaque index and bleeding on probing of 20% or lower before surgery.

Exclusion Criteria8

Systemic diseases that may affect study results (uncontrolled type 2 diabetes mellitus (HBA1c level of \>7%); recent (less than 6 months ago) myocardial infarction or stroke; blood coagulation disorders; recent use of antibiotics (less than 6 months).
Use of medications that may affect study results (anti-osteoporotic drugs, statins, corticosteroids, calcium channel blockers, cyclosporine A, antiepileptic drugs, antipsychotic medication or antidepressants, chemotherapy and/or radiotherapy (active or history)).
Current pregnancy and/or breastfeeding.
Patients who have received any form of systemic antibiotics in the last six months prior to the start of the study.
Patients who require antibiotic premedication prior to periodontal treatment.
Prosthetic factors in teeth associated with suitable bone defects that prevent clinical measurements.
Lack of patient motivation to undertake adequate dental care at home or to complete periodontal treatment.
Strong vomiting reflex preventing adequate periodontal treatment.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.